Guardian Pharmacy Services, Inc. (NYSE:GRDN) Sees Large Increase in Short Interest

Guardian Pharmacy Services, Inc. (NYSE:GRDN) was the target of a significant increase in short interest in January. As of January 15th, there was short interest totaling 1,543,962 shares, an increase of 33.3% from the December 31st total of 1,158,683 shares. Currently, 6.7% of the company’s stock are short sold. Based on an average trading volume of 280,436 shares, the days-to-cover ratio is currently 5.5 days. Based on an average trading volume of 280,436 shares, the days-to-cover ratio is currently 5.5 days. Currently, 6.7% of the company’s stock are short sold.

Guardian Pharmacy Services Trading Down 1.4%

Shares of NYSE:GRDN opened at $30.26 on Monday. The stock’s 50-day moving average price is $30.06 and its 200-day moving average price is $27.14. Guardian Pharmacy Services has a 12-month low of $17.78 and a 12-month high of $37.43. The stock has a market capitalization of $1.92 billion, a P/E ratio of 48.04 and a beta of 0.96.

Guardian Pharmacy Services (NYSE:GRDN) last announced its quarterly earnings results on Monday, November 10th. The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.01. The business had revenue of $377.43 million during the quarter, compared to analysts’ expectations of $381.16 million. Guardian Pharmacy Services had a net margin of 2.90% and a return on equity of 30.29%. As a group, research analysts predict that Guardian Pharmacy Services will post 0.87 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. Wall Street Zen raised shares of Guardian Pharmacy Services from a “buy” rating to a “strong-buy” rating in a research report on Monday, November 17th. Oppenheimer began coverage on Guardian Pharmacy Services in a research report on Friday, October 10th. They set an “outperform” rating and a $30.00 target price for the company. Stephens raised their price target on shares of Guardian Pharmacy Services from $35.00 to $36.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 14th. Truist Financial lifted their price objective on Guardian Pharmacy Services from $30.00 to $34.00 and gave the stock a “buy” rating in a report on Friday, November 14th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Guardian Pharmacy Services in a research note on Monday, December 29th. Four analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $32.00.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of GRDN. State of Alaska Department of Revenue purchased a new position in shares of Guardian Pharmacy Services during the third quarter valued at approximately $30,000. Parkside Financial Bank & Trust bought a new stake in shares of Guardian Pharmacy Services in the 2nd quarter worth $41,000. Ameritas Investment Partners Inc. increased its holdings in Guardian Pharmacy Services by 26.5% in the 3rd quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock worth $43,000 after buying an additional 345 shares in the last quarter. Raymond James Financial Inc. bought a new stake in shares of Guardian Pharmacy Services in the second quarter worth approximately $43,000. Finally, Police & Firemen s Retirement System of New Jersey grew its position in Guardian Pharmacy Services by 76.8% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 2,444 shares of the company’s stock worth $52,000 after purchasing an additional 1,062 shares during the period.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.